Balance Sheet Encompass Health Corporation

Equities

EHC

US29261A1007

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:02 11/04/2026 am IST			5-day change	1st Jan Change
107.25 ^USD	-1.00%		+10.12%	+1.05%

19/03	Encompass Health Corp. Announces Plans to Build A 40-Bed Inpatient Rehabilitation Hospital in Bear, Delaware	CI
19/03	Encompass Health Expands Delaware Presence with New Rehabilitation Hospital	MT

82830118cf2.ytdMICi_rDovTkBN9EgPZwUs39CoB4v1i7TQER-m_jc.-KB6blvU1XIaJ3l8wxBMFmBrkOOdYvzG4_-bdF3ly1KfpwZqa-rIf3YIBQ

Published financial data: ENCOMPASS HEALTH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	512.16Cr	434.86Cr	480.12Cr	537.32Cr	593.52Cr
Total Revenues	512.16Cr	434.86Cr	480.12Cr	537.32Cr	593.52Cr
Cost of Goods Sold, Total	309.58Cr	259.54Cr	281.84Cr	314Cr	337.03Cr
Gross Profit	202.58Cr	175.32Cr	198.28Cr	223.32Cr	256.49Cr
Selling General & Admin Expenses, Total	28Cr	21Cr	26Cr	27Cr	30Cr
Depreciation & Amortization - (IS)	26Cr	24Cr	27Cr	30Cr	33Cr
Other Operating Expenses	69Cr	67Cr	72Cr	79Cr	88Cr
Other Operating Expenses, Total	121.93Cr	112.3Cr	125.1Cr	135.83Cr	151.18Cr
Operating Income	81Cr	63Cr	73Cr	87Cr	105.31Cr
Interest Expense, Total	-16Cr	-18Cr	-14Cr	-14Cr	-12Cr
Net Interest Expenses	-16Cr	-18Cr	-14Cr	-14Cr	-12Cr
Income (Loss) On Equity Invest.	40L	29L	32L	30L	43L
Other Non Operating Income (Expenses)	91L	-52L	1.57Cr	2.01Cr	1.88Cr
EBT, Excl. Unusual Items	66Cr	45Cr	61Cr	76Cr	95Cr
Restructuring Charges	-	-	-	-1.04Cr	-
Gain (Loss) On Sale Of Investments	32L	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-10L	-14L	-	-6L	-
EBT, Incl. Unusual Items	66Cr	45Cr	61Cr	75Cr	95Cr
Income Tax Expense	14Cr	10Cr	13Cr	15Cr	19Cr
Earnings From Continuing Operations	52Cr	35Cr	48Cr	60Cr	76Cr
Earnings Of Discontinued Operations	-4L	1.52Cr	-1.2Cr	-28L	-10L
Net Income to Company	52Cr	37Cr	46Cr	60Cr	76Cr
Minority Interest	-10Cr	-9.49Cr	-11Cr	-14Cr	-19Cr
Net Income - (IS)	41Cr	27Cr	35Cr	46Cr	57Cr
Preferred Dividend and Other Adjustments	18L	12L	24L	28L	15L
Net Income to Common Incl Extra Items	41Cr	27Cr	35Cr	45Cr	56Cr
Net Income to Common Excl. Extra Items	41Cr	25Cr	36Cr	46Cr	57Cr
Per Share Items
Net EPS - Basic	4.15	2.72	3.51	4.53	5.62
Basic EPS - Continuing Operations	4.15	2.57	3.63	4.56	5.63
Basic Weighted Average Shares Outstanding	9.9Cr	9.92Cr	9.95Cr	9.99Cr	10Cr
Net EPS - Diluted	4.11	2.7	3.47	4.46	5.54
Diluted EPS - Continuing Operations	4.12	2.55	3.59	4.49	5.55
Diluted Weighted Average Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Normalized Basic EPS	3.07	1.89	2.7	3.35	4.01
Normalized Diluted EPS	3.04	1.87	2.65	3.27	3.94
Dividend Per Share	1.12	0.86	0.6	0.64	0.72
Payout Ratio	27.27	36.53	17.16	13.78	12.56
Supplemental Items
EBITDA	106.31Cr	87Cr	100.57Cr	117.45Cr	138.1Cr
EBITA	86Cr	66Cr	76Cr	90Cr	108.14Cr
EBIT	81Cr	63Cr	73Cr	87Cr	105.31Cr
EBITDAR	114.02Cr	93Cr	105.87Cr	122.87Cr	143.68Cr
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	21.24	22.2	21.77	20.04	20.24
Current Domestic Taxes	11Cr	7.22Cr	13Cr	14Cr	17Cr
Current Foreign Taxes	-	-	-	-	26L
Total Current Taxes	11Cr	7.22Cr	13Cr	14Cr	17Cr
Deferred Domestic Taxes	2.78Cr	2.79Cr	39L	1.07Cr	2.23Cr
Total Deferred Taxes	2.78Cr	2.79Cr	39L	1.07Cr	2.23Cr
Normalized Net Income	30Cr	19Cr	27Cr	33Cr	40Cr
Interest Capitalized	89L	1.05Cr	1.35Cr	1.52Cr	1.76Cr
Interest on Long-Term Debt	3.98Cr	3.95Cr	3.97Cr	3.99Cr	4.06Cr
Supplemental Operating Expense Items
Advertising Expense	56L	63L	61L	58L	53L
Selling and Marketing Expenses	-	-	-	-	53L
General and Administrative Expenses	20Cr	15Cr	20Cr	21Cr	24Cr
Net Rental Expense, Total	7.71Cr	5.18Cr	5.3Cr	5.42Cr	5.58Cr
Imputed Operating Lease Interest Expense	3.02Cr	2.38Cr	2.25Cr	2.34Cr	2.32Cr
Imputed Operating Lease Depreciation	4.69Cr	2.8Cr	3.05Cr	3.08Cr	3.26Cr
Stock-Based Comp., G&A Exp. (Total)	3.28Cr	2.92Cr	5.06Cr	4.83Cr	5.65Cr
Total Stock-Based Compensation	3.28Cr	2.92Cr	5.06Cr	4.83Cr	5.65Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.48Cr	2.18Cr	6.91Cr	8.54Cr	7.22Cr
Total Cash And Short Term Investments	5.48Cr	2.18Cr	6.91Cr	8.54Cr	7.22Cr
Accounts Receivable, Total	67Cr	52Cr	60Cr	59Cr	61Cr
Other Receivables	1.37Cr	1.2Cr	1.18Cr	58L	58L
Total Receivables	68Cr	54Cr	61Cr	60Cr	62Cr
Prepaid Expenses	12Cr	9.61Cr	3.45Cr	4.23Cr	5.39Cr
Restricted Cash	6.51Cr	3.16Cr	3.51Cr	3.77Cr	3.07Cr
Other Current Assets, Total	-	3.09Cr	9.15Cr	12Cr	13Cr
Total Current Assets	92Cr	72Cr	84Cr	89Cr	91Cr
Gross Property Plant And Equipment	438.3Cr	481.11Cr	538.17Cr	595.87Cr	668.7Cr
Accumulated Depreciation	-153.94Cr	-165.94Cr	-187.22Cr	-211.19Cr	-237.28Cr
Net Property Plant And Equipment	284.36Cr	315.17Cr	350.95Cr	384.68Cr	431.42Cr
Long-term Investments	40L	-	-	-	-
Goodwill	242.79Cr	126.32Cr	128.13Cr	128.4Cr	131.76Cr
Other Intangibles, Total	42Cr	28Cr	28Cr	30Cr	31Cr
Accounts Receivable Long-Term	8.35Cr	7.33Cr	2.09Cr	3.06Cr	2.55Cr
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	17Cr	15Cr	17Cr	19Cr	22Cr
Total Assets	686.49Cr	563.65Cr	610.24Cr	653.47Cr	708.97Cr
Liabilities
Accounts Payable, Total	14Cr	13Cr	17Cr	17Cr	18Cr
Accrued Expenses, Total	36Cr	26Cr	30Cr	32Cr	30Cr
Current Portion of Long-Term Debt	1.97Cr	57L	32L	11Cr	1.71Cr
Current Portion of Leases	6.15Cr	4.51Cr	4.57Cr	5Cr	5.3Cr
Other Current Liabilities	17Cr	13Cr	13Cr	18Cr	29Cr
Total Current Liabilities	75Cr	58Cr	66Cr	84Cr	84Cr
Long-Term Debt	285.22Cr	237.35Cr	234.13Cr	203.65Cr	215.11Cr
Long-Term Leases	60Cr	57Cr	54Cr	51Cr	49Cr
Deferred Tax Liability Non Current	8.67Cr	8.3Cr	8.7Cr	11Cr	13Cr
Other Non Current Liabilities	17Cr	17Cr	18Cr	19Cr	21Cr
Total Liabilities	446.57Cr	377.46Cr	380.52Cr	368.55Cr	381.39Cr
Common Stock, Total	11L	11L	12L	12L	12L
Additional Paid In Capital	228.96Cr	173.02Cr	178.7Cr	184.7Cr	186.96Cr
Retained Earnings	14Cr	12Cr	41Cr	80Cr	128.94Cr
Treasury Stock	-52Cr	-54Cr	-55Cr	-58Cr	-72Cr
Comprehensive Income and Other	-	-	-	-	5L
Total Common Equity	191.13Cr	131.03Cr	164.75Cr	206.7Cr	243.82Cr
Minority Interest	49Cr	55Cr	65Cr	78Cr	84Cr
Total Equity	239.92Cr	186.19Cr	229.72Cr	284.92Cr	327.58Cr
Total Liabilities And Equity	686.49Cr	563.65Cr	610.24Cr	653.47Cr	708.97Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.94Cr	9.97Cr	10Cr	10Cr	9.94Cr
ECS Total Common Shares Outstanding	9.95Cr	9.98Cr	10Cr	10Cr	10Cr
Book Value / Share	19.21	13.13	16.43	20.51	24.38
Tangible Book Value	-93Cr	-24Cr	8.8Cr	49Cr	81Cr
Tangible Book Value Per Share	-9.39	-2.36	0.88	4.81	8.12
Total Debt	353.82Cr	299.23Cr	293.28Cr	271.38Cr	271.39Cr
Net Debt	348.34Cr	297.05Cr	286.37Cr	262.84Cr	264.17Cr
Debt Equivalent Oper. Leases	62Cr	41Cr	42Cr	43Cr	45Cr
Minority Interest, Total (Incl. Fin. Div)	49Cr	55Cr	65Cr	78Cr	84Cr
Equity Method Investments, Total	24L	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	26Cr	29Cr	29Cr	30Cr	34Cr
Buildings, Total	263.28Cr	301.98Cr	340.28Cr	385.93Cr	432.57Cr
Machinery, Total	64Cr	65Cr	73Cr	81Cr	90Cr
Full Time Employees	28T	20.84T	22.36T	23.56T	24.61T
Part Time Employees	2.59T	2.56T	2.95T	3.25T	3.32T
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	41Cr	27Cr	35Cr	46Cr	57Cr
Depreciation & Amortization - CF	20Cr	21Cr	24Cr	27Cr	30Cr
Amortization of Goodwill and Intangible Assets - (CF)	5.64Cr	2.88Cr	3.25Cr	2.88Cr	2.83Cr
Depreciation & Amortization, Total	26Cr	24Cr	27Cr	30Cr	33Cr
Amortization of Deferred Charges, Total - (CF)	78L	97L	95L	97L	96L
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-11L	11L	-16L	10L	-2L
Stock-Based Compensation (CF)	3.28Cr	2.92Cr	5.06Cr	4.83Cr	5.65Cr
Provision and Write-off of Bad Debts	-	-	-	-	-
Net Cash From Discontinued Operations	-5L	5.23Cr	-1.6Cr	-31L	-14L
Other Operating Activities, Total	13Cr	13Cr	13Cr	17Cr	21Cr
Change In Accounts Receivable	-6.43Cr	-1.69Cr	-2.24Cr	30L	-1.52Cr
Change In Accounts Payable	1.49Cr	23L	1.18Cr	30L	-2.26Cr
Change in Other Net Operating Assets	-6.86Cr	-1.58Cr	6.09Cr	1.59Cr	4.21Cr
Cash from Operations	72Cr	71Cr	85Cr	100.28Cr	117.56Cr
Capital Expenditure	-53Cr	-56Cr	-58Cr	-64Cr	-74Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-12Cr	-	-	-	-
Sale (Purchase) of Intangible assets	-2.23Cr	-1.93Cr	-	-	-
Other Investing Activities, Total	35L	-4.29Cr	-1.97Cr	-1.08Cr	-2.82Cr
Cash from Investing	-67Cr	-63Cr	-60Cr	-65Cr	-76Cr
Long-Term Debt Issued, Total	30Cr	25Cr	8Cr	9.5Cr	21Cr
Total Debt Issued	30Cr	25Cr	8Cr	9.5Cr	21Cr
Long-Term Debt Repaid, Total	-37Cr	-75Cr	-16Cr	-34Cr	-24Cr
Total Debt Repaid	-37Cr	-75Cr	-16Cr	-34Cr	-24Cr
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.64Cr	-73L	-82L	-4.32Cr	-18Cr
Common Dividends Paid	-11Cr	-9.9Cr	-6.04Cr	-6.28Cr	-7.11Cr
Common & Preferred Stock Dividends Paid	-11Cr	-9.9Cr	-6.04Cr	-6.28Cr	-7.11Cr
Other Financing Activities, Total	-4.5Cr	46Cr	-4.53Cr	1.74Cr	-15Cr
Cash from Financing	-24Cr	-15Cr	-20Cr	-33Cr	-43Cr
Net Change in Cash	-19Cr	-6.69Cr	5.08Cr	1.89Cr	-2.02Cr
Supplemental Items
Cash Interest Paid	17Cr	18Cr	15Cr	15Cr	13Cr
Cash Income Tax Paid (Refund)	13Cr	5.02Cr	11Cr	16Cr	-
Levered Free Cash Flow	3.86Cr	-33.38L	12Cr	22Cr	30Cr
Unlevered Free Cash Flow	13Cr	9.68Cr	20Cr	29Cr	36Cr
Change In Net Working Capital	11Cr	-1.42Cr	-51L	-3.98Cr	-5.8Cr
Net Debt Issued / Repaid	-6.63Cr	-50Cr	-8.33Cr	-24Cr	-2.9Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.57	6.3	7.79	8.65	9.66
Return on Total Capital	8.78	7.34	9.07	10.13	11.39
Return On Equity %	23.52	16.46	22.84	23.29	24.82
Return on Common Equity	23.48	15.81	24.45	24.54	25.11
Margin Analysis
Gross Profit Margin %	39.55	40.32	41.3	41.56	43.22
SG&A Margin	5.42	4.81	5.37	4.96	5.06
EBITDA Margin %	20.76	20.09	20.95	21.86	23.27
EBITA Margin %	16.85	15.15	15.92	16.82	18.22
EBIT Margin %	15.75	14.49	15.24	16.28	17.74
Income From Continuing Operations Margin %	10.11	8.06	9.89	11.16	12.81
Net Income Margin %	8.05	6.23	7.33	8.48	9.54
Net Avail. For Common Margin %	8.02	5.85	7.53	8.48	9.53
Normalized Net Income Margin	5.94	4.32	5.59	6.22	6.79
Levered Free Cash Flow Margin	0.75	-0.08	2.58	4.02	5
Unlevered Free Cash Flow Margin	2.61	2.23	4.25	5.43	6.14
Asset Turnover
Asset Turnover	0.77	0.7	0.82	0.85	0.87
Fixed Assets Turnover	1.93	1.47	1.44	1.46	1.45
Receivables Turnover (Average Receivables)	8.33	8.47	8.54	9.01	9.84
Short Term Liquidity
Current Ratio	1.23	1.25	1.28	1.05	1.08
Quick Ratio	0.98	0.97	1.04	0.81	0.83
Operating Cash Flow to Current Liabilities	0.96	1.23	1.3	1.19	1.41
Days Sales Outstanding (Average Receivables)	43.81	43.1	42.75	40.62	37.09
Average Days Payable Outstanding	14.89	18.77	19.61	19.87	18.91
Long Term Solvency
Total Debt/Equity	147.47	160.71	127.67	95.25	82.85
Total Debt / Total Capital	59.59	61.64	56.08	48.78	45.31
LT Debt/Equity	144.09	157.98	125.54	89.46	80.71
Long-Term Debt / Total Capital	58.22	60.6	55.14	45.82	44.14
Total Liabilities / Total Assets	65.05	66.97	62.36	56.4	53.79
EBIT / Interest Expense	4.9	3.59	5.1	6.37	8.55
EBITDA / Interest Expense	6.93	5.27	7.38	8.94	11.66
(EBITDA - Capex) / Interest Expense	3.71	2.05	3.31	4.27	5.69
Total Debt / EBITDA	3.1	3.23	2.77	2.21	1.89
Net Debt / EBITDA	3.06	3.21	2.7	2.14	1.84
Total Debt / (EBITDA - Capex)	5.79	8.29	6.17	4.63	3.87
Net Debt / (EBITDA - Capex)	5.7	8.23	6.02	4.48	3.77
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.27	8.31	10.41	11.91	10.46
Gross Profit, 1 Yr. Growth %	14.98	2.92	13.1	12.63	14.85
EBITDA, 1 Yr. Growth %	19.34	-0.59	15.09	16.78	17.58
EBITA, 1 Yr. Growth %	21.95	-4.58	15.98	18.24	19.66
EBIT, 1 Yr. Growth %	24.5	-4.43	16.12	19.55	20.37
Earnings From Cont. Operations, 1 Yr. Growth %	40.35	-13	35.44	26.19	26.81
Net Income, 1 Yr. Growth %	45.04	-34.26	29.89	29.46	24.25
Normalized Net Income, 1 Yr. Growth %	43.18	-11.14	42.04	24.57	20.41
Diluted EPS Before Extra, 1 Yr. Growth %	44.6	-14.36	40.32	24.85	23.71
Accounts Receivable, 1 Yr. Growth %	18.4	4.52	14.29	-1.13	3.44
Net Property, Plant and Equip., 1 Yr. Growth %	15.96	13.58	11.35	9.61	12.15
Total Assets, 1 Yr. Growth %	6.5	-17.89	8.27	7.08	8.49
Tangible Book Value, 1 Yr. Growth %	-19.61	-145.59	-137.41	451.36	67.42
Common Equity, 1 Yr. Growth %	20.36	-31.44	25.73	25.46	17.96
Cash From Operations, 1 Yr. Growth %	1.58	-1.4	20.54	17.87	17.23
Capital Expenditures, 1 Yr. Growth %	33.56	7.66	-0.17	10.19	14.61
Levered Free Cash Flow, 1 Yr. Growth %	-57.39	-95.48	-3.81T	74.5	37.5
Unlevered Free Cash Flow, 1 Yr. Growth %	-32.66	360.29	110.67	43.23	24.72
Dividend Per Share, 1 Yr. Growth %	0	-23.21	-30.23	6.67	12.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.46	10.42	9.35	11.16	11.18
Gross Profit, 2 Yr. CAGR %	4.25	8.42	7.89	12.86	13.74
EBITDA, 2 Yr. CAGR %	8.01	9.15	6.96	15.94	17.18
EBITA, 2 Yr. CAGR %	7.2	8.16	5.2	17.1	18.95
EBIT, 2 Yr. CAGR %	7.92	9	5.35	17.83	19.96
Earnings From Cont. Operations, 2 Yr. CAGR %	7.68	12.28	8.55	30.73	26.5
Net Income, 2 Yr. CAGR %	7.2	-2.35	-7.59	29.67	26.83
Normalized Net Income, 2 Yr. CAGR %	8.8	16.15	12.26	33.02	22.47
Diluted EPS Before Extra, 2 Yr. CAGR %	6.73	14.6	9.57	32.36	24.28
Accounts Receivable, 2 Yr. CAGR %	15.61	-3.45	9.3	6.3	1.13
Net Property, Plant and Equip., 2 Yr. CAGR %	12.78	13.37	12.46	10.48	10.87
Total Assets, 2 Yr. CAGR %	6.25	-6.49	-5.72	7.67	7.79
Tangible Book Value, 2 Yr. CAGR %	-19.16	-55.01	-58.7	43.63	203.82
Common Equity, 2 Yr. CAGR %	18.89	-9.16	-7.16	25.6	21.65
Cash From Operations, 2 Yr. CAGR %	6.15	0.08	9.02	19.2	17.55
Capital Expenditures, 2 Yr. CAGR %	19.17	19.91	3.37	4.88	12.38
Levered Free Cash Flow, 2 Yr. CAGR %	-56.4	-61.75	29.4	704.18	54.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	-33.06	6.83	211.4	73.71	33.65
Dividend Per Share, 2 Yr. CAGR %	0.9	-12.37	-26.81	-13.73	9.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.19	-1.89	10.42	10.2	10.92
Gross Profit, 3 Yr. CAGR %	4.71	-2.02	9.96	9.45	13.52
EBITDA, 3 Yr. CAGR %	6.45	-1.39	11.1	10.14	16.48
EBITA, 3 Yr. CAGR %	5.59	-4.26	10.71	9.38	17.95
EBIT, 3 Yr. CAGR %	5.77	-3.09	11.33	9.88	18.67
Earnings From Cont. Operations, 3 Yr. CAGR %	11.41	-7.73	19.52	14.14	29.41
Net Income, 3 Yr. CAGR %	12.14	-8.92	7.39	3.4	27.84
Normalized Net Income, 3 Yr. CAGR %	5.71	-9.96	24.5	16.22	28.68
Diluted EPS Before Extra, 3 Yr. CAGR %	12.17	-11.01	22.81	14.44	29.41
Accounts Receivable, 3 Yr. CAGR %	13.17	1.72	2.13	5.7	5.34
Net Property, Plant and Equip., 3 Yr. CAGR %	20.26	12.13	12.69	11.5	11.03
Total Assets, 3 Yr. CAGR %	9.88	-2.5	-1.81	-1.63	7.95
Tangible Book Value, 3 Yr. CAGR %	-9.67	-45.2	-57.69	-2.02	51.16
Common Equity, 3 Yr. CAGR %	14.4	-1.04	1.23	2.64	23
Cash From Operations, 3 Yr. CAGR %	-2.08	3.57	6.48	11.89	18.54
Capital Expenditures, 3 Yr. CAGR %	27.61	14.89	14.08	5.59	8.03
Levered Free Cash Flow, 3 Yr. CAGR %	-58.85	-74.57	75.68	42.97	346.35
Unlevered Free Cash Flow, 3 Yr. CAGR %	-40.73	-31.29	33.96	140.37	55.54
Dividend Per Share, 3 Yr. CAGR %	2.5	-7.88	-18.78	-17.02	-5.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.05	2.13	2.34	3.13	10.72
Gross Profit, 5 Yr. CAGR %	5.96	1.72	2.36	3.68	11.45
EBITDA, 5 Yr. CAGR %	5.23	0.96	2.68	5.21	13.49
EBITA, 5 Yr. CAGR %	4.28	-1.16	0.84	3.77	13.93
EBIT, 5 Yr. CAGR %	4.37	-0.6	1.43	4.79	14.7
Earnings From Cont. Operations, 5 Yr. CAGR %	10.23	0.01	4.88	6.07	22.27
Net Income, 5 Yr. CAGR %	10.73	-0.01	3.79	4.9	14.78
Normalized Net Income, 5 Yr. CAGR %	5.14	-4.62	0.83	5.4	23.68
Diluted EPS Before Extra, 5 Yr. CAGR %	9.75	-2.17	4.25	4.42	23.4
Accounts Receivable, 5 Yr. CAGR %	9.06	2.69	5.46	3.52	1.73
Net Property, Plant and Equip., 5 Yr. CAGR %	15.36	15.75	16.51	11.46	11.96
Total Assets, 5 Yr. CAGR %	7.95	2.99	3.35	1.45	1.92
Tangible Book Value, 5 Yr. CAGR %	-10.23	-28.09	-41.34	-19.43	-6.91
Common Equity, 5 Yr. CAGR %	21.03	2.6	5.23	8.86	8.95
Cash From Operations, 5 Yr. CAGR %	2.26	1.4	2.22	9.56	10.78
Capital Expenditures, 5 Yr. CAGR %	24.38	20.13	18.04	11.53	13.39
Levered Free Cash Flow, 5 Yr. CAGR %	-32.84	-59.7	-25.9	1.23	67.05
Unlevered Free Cash Flow, 5 Yr. CAGR %	-18.69	-24.77	-20.5	-0.43	33.84
Dividend Per Share, 5 Yr. CAGR %	3.57	-2.58	-10.42	-10.27	-8.46